• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Technology

This robotic capsule could deliver large-protein drugs like insulin

September 28, 2022 By Sean Whooley

MIT Robot Drug Delivery

Researchers at the Massachusetts Institute of Technology (MIT) developed a new drug capsule with a robotic cap for improved drug delivery. Large-protein drugs generally can’t pass through the mucus barrier that lines the digestive tract. Insulin and most other “biologic drugs” with proteins or nucleic acids thus must be injected or administered in a hospital, […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Technology Tagged With: Diabetes, insulin, Massachusetts Institute of Technology, robotics

7 innovative digital health offerings to treat diabetes

September 28, 2022 By Sean Whooley

MIT Insulin Dosing device diabetes

From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Better Therapeutics, dariohealth, Dexcom, Diabetes, Glytec, Onduo, One Drop, Sword Health, Verily, Virta Health, Zillion

Better Therapeutics submits FDA de novo request for type 2 diabetes treatment

September 22, 2022 By Sean Whooley

Better Therapeutics

Better Therapeutics (Nasdaq:BTTX) announced today that it submitted a de novo classification request to the FDA for its BT-001 technology. San Francisco-based Better Therapeutics seeks marketing authorization for the BT-001 prescription digital therapeutic (PDT). It potentially represents the first-in-class PDT using cognitive behavioral therapy (CBT) to treat type 2 diabetes. Marketing initially would cover type […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: Better Therapeutics, FDA

JDRF launches Type 1 Diabetes Index simulation tool

September 21, 2022 By Sean Whooley

JDRF - updated logo

JDRF announced today that it launched the Type 1 Diabetes Index (T1D Index) data simulation tool for measuring the impact of T1D around the globe. The tool measures the human and public health impact type 1 diabetes has in every country. JDRF said it addresses wide gaps in data about the incidence and impact of […]

Filed Under: Big Data, Business/Financial News, Diabetes, Featured, Technology Tagged With: Juvenile Diabetes Research Foundation (JDRF)

Study backs automated insulin delivery system from Diabeloop

September 21, 2022 By Sean Whooley

Diabeloop DBLG1 automated insulin delivery System

Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system. Paris-based Diabeloop evaluated DBLG1 in a large, multi-country patient cohort. Results demonstrated constant improvement in time in range and time in hypoglycemia remaining significantly low. The company said in a news release that the results, combined with trust in its algorithm, […]

Filed Under: Auto-injectors, Big Data, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Diabeloop

Medtronic, FDA warn on potential cybersecurity risk with MiniMed insulin pump

September 20, 2022 By Sean Whooley

Medtronic MiniMed 670g insulin pump

Medtronic (NYSE:MDT) issued an urgent medical device correction notice to warn of potential issues with some MiniMed automated insulin delivery systems. The notice — dated this month — covers the company’s MiniMed 600 series insulin pumps (MiniMed 630G and 670G). Affected devices also include the Guardian Link 3 transmitter, Contour Next Link 2.4 blood glucose […]

Filed Under: Auto-injectors, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pain Management, Recalls, Technology Tagged With: FDA, Medtronic

CISA warns on cybersecurity vulnerabilities for certain Baxter infusion pumps

September 8, 2022 By Sean Whooley

Baxter

The U.S. Cybersecurity and Infrastructure Security Agency (CISA) today issued a warning on some Baxter (NYSE:BAX) infusion pumps. Sigma and Baxter Spectrum infusion pumps are included in a CISA notice over remotely exploitable vulnerabilities. Those vulnerabilities include: missing description of sensitive data, use of externally controlled format string and missing authentication for critical functions. The […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: Baxter

Virta Health diabetes reversal produces positive outcomes in 90-day study

September 8, 2022 By Sean Whooley

Virta Health

Virta Health announced today that a partnership with U-Haul demonstrated positive outcomes from its type 2 diabetes reversal treatement. San Francisco-based Virta — launched in 2017  — aims to reverse type 2 diabetes. It designed its technology platform to enable personalized remote care. Its offerings include physician supervision, health coaches, an app and biomarker tracking […]

Filed Under: Diabetes, Technology Tagged With: Virta Health

Study shows workplace productivity improvements with One Drop type 2 diabetes tech

August 26, 2022 By Sean Whooley

One Drop technology

One Drop today announced positive results from a trial of its digital health platform for people with type 2 diabetes. Employees using the One Drop digital diabetes management platform experienced significant productivity and functioning gains and were less likely to experience presenteeism at follow-up compared to control groups. One Drop’s platform uses AI to provide […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: One Drop

Glytec, CPS collaborate on glycemic management support for pharmacy departments

August 23, 2022 By Sean Whooley

Glytec

Glytec announced today that CPS Solutions selected it to serve as an insulin management technology resource. Waltham, Massachusetts-based Glytec will serve as a resource for CPS’ more than 2,200 pharmacy professionals across more than 800 healthcare facilities nationwide. Through the collaboration, CPS client facilities can contract for Glytec’s eGlycemic Management System (eGMS) and Glytec’s technical […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: CPS Solutions, Glytec

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Page 61
  • Interim pages omitted …
  • Page 75
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS